Complete Paternal Isodisomy of Chromosome 17 in Junctional Epidermolysis Bullosa with Pyloric Atresia  by Natsuga, Ken et al.
Department of Health (AF0301). We thank
Dr Michele Weiss for the figure illustration.
Fred M. Kaplan1,
Michael J. Mastrangelo2,3 and
Andrew E. Aplin1,3
1Department of Cancer Biology, Thomas
Jefferson University, Philadelphia,
Pennsylvania, USA; 2Department of Medical
Oncology, Thomas Jefferson University,
Philadelphia, Pennsylvania, USA and
3Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, Pennsylvania,
USA
E-mail: Fred.Kaplan@mail.jc.tju.edu or
Andrew.Aplin@KimmelCancerCenter.Org
REFERENCES
Davies H, Bignell GR, Cox C et al. (2002)
Mutations of the BRAF gene in human
cancer. Nature 417:949–54
Flaherty K, Puzanov I, Sosman J et al. (2009)
Phase I study of PLX4032: proof of concept
for V600E BRAF mutation as a therapeutic
target in human cancer. J Clin Oncol 27:
15S (Abstract)
Halaban R, Zhang W, Bacchiocchi A et al.
(2010) PLX4032, a selective BRAF V600E
kinase inhibitor, activates the ERK
pathway and enhances cell migration and
proliferation of BRAF WT melanoma
cells. Pigment Cell Melanoma Res 23:
190–200
Hall-Jackson CA, Eyers PA, Cohen P et al. (1999)
Paradoxical activation of Raf by a novel Raf
inhibitor. Chem Biol 6:559–68
Hatzivassiliou G, Song K, Yen I et al. (2010) RAF
inhibitors prime wild-type RAF to activate the
MAPK pathway and enhance growth. Nature
464:431–5
Heidorn SJ, Milagre C, Whittaker S et al. (2010)
Kinase-dead BRAF and oncogenic RAS co-
operate to drive tumor progression through
CRAF. Cell 140:209–21
King AJ, Patrick DR, Batorsky RS et al. (2006)
Demonstration of a genetic therapeutic index
for tumors expressing oncogenic BRAF by
the kinase inhibitor SB-590885. Cancer Res
66:11100–5
Michaloglou C, Vredeveld LC, Mooi WJ et al.
(2008) BRAF(E600) in benign and malignant
human tumours. Oncogene 27:877–95
Poulikakos PI, Zhang C, Bollag G et al. (2010) RAF
inhibitors transactivate RAF dimers and ERK
signalling in cells with wild-type BRAF.
Nature 464:427–30
Ritt DA, Monson DM, Specht SI et al. (2010)
Impact of feedback phosphorylation and Raf
heterodimerization on normal and mutant
B-Raf signaling. Mol Cell Biol 30:806–19
Rushworth LK, Hindley AD, O’Neill E et al. (2006)
Regulation and role of Raf-1/B-Raf hetero-
dimerization. Mol Cell Biol 26:2262–72
Tsai J, Lee JT, Wang W et al. (2008) Discovery of a
selective inhibitor of oncogenic B-Raf kinase
with potent antimelanoma activity. Proc Natl
Acad Sci USA 105:3041–6
Complete Paternal Isodisomy of Chromosome 17 in
Junctional Epidermolysis Bullosa with Pyloric Atresia
Journal of Investigative Dermatology (2010) 130, 2671–2674; doi:10.1038/jid.2010.182; published online 1 July 2010
TO THE EDITOR
Uniparental disomy (UPD) is a condi-
tion in which two chromosomes of the
same pair are inherited in whole or in
part from only one parent. There are
two types of UPD: uniparental isodis-
omy and uniparental heterodisomy.
The former refers to two identical
copies of a single homolog of a
chromosome from one parent, and the
latter indicates two different chromo-
some homologs from one parent. UPD
can lead to an abnormal phenotype
when isodisomy for a chromosome
carrying a mutation for an autosomal-
recessive disease gene results in homo-
zygosity for the mutation.
Epidermolysis bullosa (EB) is a col-
lection of heterogeneous disorders, in
which congenital skin fragility leads to
separation of the dermo-epidermal junc-
tion. EB has been subdivided into three
major groups and one minor group,
based on the level of blister formation:
EB simplex, junctional EB, (JEB), dys-
trophic EB, and Kindler syndrome
(Fine et al., 2008). Mutations in 14
different genes have been identified as
underlying EB subtypes (Fine et al.,
2008; Groves et al., 2010). Among
them, mutations in the gene encoding
a6 integrin subunit (ITGA6) or b4
integrin subunit (ITGB4) are responsible
for one rare subtype of JEB: JEB
associated with pyloric atresia (JEB-
PA). JEB-PA is inherited autosomal
recessively and is characterized by
generalized blistering and occlusion of
the pylorus at birth, which usually leads
to early demise. Most patients with JEB-
PA have mutations in ITGB4, and more
than 60 ITGB4 mutations have been
identified in JEB-PA cases.
The proband was the first child of
nonconsanguineous healthy parents.
There was no family history of bullous
diseases. The child was born by cesar-
ean section after a 35-week gestation
because of polyhydramnion and had
a birth weight of 1916 g and a birth
length of 46.5 cm. Clinical manifesta-
tions of the proband included
extensive blistering, especially on the
extremities (Figure 1a). Routine abdom-
inal X-ray demonstrated pyloric atresia
(PA) (Figure 1b). No abnormalities
other than skin fragility and PA were
apparent. The proband died of sepsis 2
months after birth.
Immunofluorescence analysis re-
vealed an absence of the b4 integrin
subunit in skin specimens from the
proband (Figure 1c–f). Expression of a6
integrin subunit and plectin was reduced
in proband skin samples (Figure 1g
and h). Immunostaining for BP230,
laminin 332, and type VII collagen
revealed normal linear-labeling pat-
terns (Figure 1i–k).
Mutational analysis of all coding
exons (exons 2–41) including the exon–
intron boundaries of the ITGB4 revea-
led that the proband was homozygous
for c.953_955del in exon 8 (Figure 2a).
The genomic DNA nucleotides, the
Abbreviations: EB, epidermolysis bullosa; JEB, junctional EB; JEB-PA, JEB with pyloric atresia; ITGA6, a6
integrin subunit; ITGB4, b4 integrin subunit; UPD, uniparental disomy
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complementary DNA nucleotides and
the amino acids of the protein were
numbered based on the follo-
wing sequence information (GenBank
accession no. NM_000213). Mutation
c.953_955del is predicted to result in
the loss of asparagine at amino acid
position 318 (p.Asn318del, Figure 2b),
and this deletion mutation is not ex-
pected to cause subsequent frame-shift
followed by a premature termination
codon. Mutation c.953_955del was
previously described in two JEB-PA
cases (Iacovacci et al., 2003; Varki
et al., 2006). The proband’s father
was heterozygous for this mutation
(Figure 2a), although her mother revealed
only normal sequences (Figure 2a).
To elucidate the origin of c.953_
955del homozygosity in the proband,
haplotype analysis of the entire chro-
mosome 17 using 15 microsatellite
markers (the ABI Prism Linkage Map-
ping Set Version 2.5 (Applied Biosys-
tems, Warrington, UK)) was performed.
The proband was found to be homo-
zygous for all 15 microsatellite markers
(Figure 2d). Ten of the 15 markers were
fully informative for inheritance of two
copies of a single paternal chromosome
17 in the proband (Figure 2d). For the
non-chromosome 17 markers (D1S468,
D1S252, D1S2842, D3S1297, D3S1566
and D3S1311), there were no discrepan-
cies in the segregation of maternal and
paternal alleles to the proband, confirm-
ing that the mother is indeed the
biological mother of the patient (data
not shown). Normal karyotyping ruled
out monosomy of chromosome 17. The
results in this family are compatible with
the inheritance of two identical copies of
a single chromosome 17 from the pro-
band’s father, which indicates complete
paternal isodisomy of chromosome 17 in
the proband. The medical ethical com-
mittee of Hokkaido University approved
all the described studies. The study was
conducted according to the Declaration
of Helsinki Principles. Participants gave
their written informed consent.
A recent review of the literature on
UPD summarized 197 maternal and 68
paternal cases of UPD (Kotzot and
Utermann, 2005). For UPDs of chromo-
some 17, only a few cases of maternal
heterodisomy have been described
(Genuardi et al., 1999; Rio et al.,
2001). Recently, UPD of the whole
chromosome 17 was reported as ma-
ternal heterodisomy of 17q and prox-
imal 17p, and isodisomy of distal 17p
(Lebre et al., 2009). As far as we know,
uniparental isodisomy of the whole
chromosome 17 has not been described
in the literature.
More than 35 cases of recessive-
inherited disease have been reported as
being caused by UPD (Kotzot and
Utermann, 2005). UPD has been re-
ported to be responsible for several EB
subtypes, including Herlitz JEB (Castori
et al., 2008; Fassihi et al., 2005;
Pulkkinen et al., 1997; Takizawa et al.,
2000; Takizawa et al., 1998), EB simplex
with pyloric atresia (Nakamura et al.,
2005) and recessive dystrophic EB (Fas-
sihi et al., 2006). So far, JEB-PA has not
been described to result from UPD.
p.Asn318del (c.953_955del) has been
identified as responsible for JEB-PA
in two reports (Iacovacci et al., 2003;
Varki et al., 2006). Asn318 in b4 integrin
subunit resides in the extracellular
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Figure 1. Clinical features of the proband and immunofluorescence analysis. (a) Extensive blistering is seen on the extremities at birth. (b) Abdominal X-ray
reveals a single-bubble sign (arrows). b4 integrin subunit (3E1 (c), 113C (d), 450-9D (e), and 450-11A (f)) is not detected in the proband’s skin (arrows).
The expression of a6 integrin subunit (GoH3, g) and plectin (HD1-121, h) is diminished (arrowheads). BP230 (S1193, i), laminin-332 (GB3, j), and type VII
collagen (LH7.2, k) show a normal linear staining pattern (scale bar¼ 100mm). HD1-121 was donated by Professor Owaribe of Nagoya University,
113C by Professor Sonnenberg of the Netherlands Cancer Institute, 450-9D and 450-11A by Professor Lankford of the Oak Ridge National Laboratory, and
S1193 by Professor Stanley of the University of Pennsylvania.
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domain of the protein (Figure 2b). This
asparagine residue is an amino acid that
is conserved not only in the b4 integrin
subunit of vertebrates but in all the human
integrin-b chains (Iacovacci et al., 2003).
The 3D structure of the N-terminal
portion of the extracellular domain in-
dicates that Asn318 consists of a linking
loop between the a helix and the b sheet
(Figure 2c). It is possible that the loss of
this asparagine in the extracellular do-
main leads to significant conformational
change and protein instability.
In summary, to our knowledge, we
have reported the first case of complete
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Figure 2. ITGB4 mutation analysis. (a) The proband is homozygous for c.953_955 del (arrow). The proband’s father is heterozygous for c.953_955 del (arrow).
In contrast, the mother’s gDNA shows only wild-type sequences. Deleted nucleotides are underlined. (b) Schematic arrangement of b4 integrin subunit and the
positions of the mutation in the proband. (c) 3D imaging of the N-terminal extracellular domain of the integrin b chain (NCBI Conserved Domain Database
(code: smart00187)) was done using Cn3D-4.1 software. Asn318 is in the linking loop between the a helix and the b sheet (arrow). (d) The proband was
homozygous for all 15 microsatellite markers spanning all of chromosome 17. Ten of the 15 markers (*) suggest that the proband’s alleles originated from one
homolog of paternal chromosome 17.
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isodisomy of chromosome 17 and the first
example of UPD underlying JEB-PA.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Professor Jouni Uitto for his critical
comments on the present case, Ms Yuko Hayaka-
wa and Ms Yuki Miyamura for their technical
assistance, and Mr Michael O’Connell for his
proofreading. This work was supported in part by
grants-in-aid from the Ministry of Education,
Culture, Sports, Science and Technology to
H. Shimizu (Kiban A 21249063).
Ken Natsuga1, Wataru Nishie1,
Ken Arita1, Satoru Shinkuma1,
Hideki Nakamura1, Shogo Kubota2,
Sumihisa Imakado3, Masashi Akiyama1
and Hiroshi Shimizu1
1Department of Dermatology, Hokkaido
University Graduate School of Medicine,
Sapporo, Japan; 2Department of Pediatrics,
Japanese Red Cross Medical Center, Tokyo,
Japan and 3Department of Dermatology,
Japanese Red Cross Medical Center,
Tokyo, Japan
E-mail: natsuga@med.hokudai.ac.jp
REFERENCES
Castori M, Floriddia G, Pisaneschi E et al. (2008)
Complete maternal isodisomy causing reduc-
tion to homozygosity for a novel LAMB3
mutation in Herlitz junctional epidermolysis
bullosa. J Dermatol Sci 51:58–61
Fassihi H, Lu L, Wessagowit V et al. (2006)
Complete maternal isodisomy of chromo-
some 3 in a child with recessive dystrophic
epidermolysis bullosa but no other pheno-
typic abnormalities. J Invest Dermatol 126:
2039–43
Fassihi H, Wessagowit V, Ashton GH et al. (2005)
Complete paternal uniparental isodisomy of
chromosome 1 resulting in Herlitz junctional
epidermolysis bullosa. Clin Exp Dermatol
30:71–4
Fine JD, Eady RA, Bauer EA et al. (2008) The
classification of inherited epidermolysis bul-
losa (EB): Report of the Third International
Consensus Meeting on Diagnosis and Classi-
fication of EB. J Am Acad Dermatol
58:931–50
Genuardi M, Tozzi C, Pomponi MG et al. (1999)
Mosaic trisomy 17 in amniocytes: phenotypic
outcome, tissue distribution, and uniparental
disomy studies. Eur J Hum Genet 7:421–6
Groves RW, Liu L, Dopping-Hepenstal PJ et al.
(2010) A homozygous nonsense mutation
within the dystonin gene coding for the
coiled-coil domain of the epithelial isoform
of BPAG1 underlies a new subtype of
autosomal recessive epidermolysis bullosa
simplex. J Invest Dermatol 130:1551–7
Iacovacci S, Cicuzza S, Odorisio T et al. (2003)
Novel and recurrent mutations in the integrin
beta 4 subunit gene causing lethal junctional
epidermolysis bullosa with pyloric atresia.
Exp Dermatol 12:716–20
Kotzot D, Utermann G (2005) Uniparental disomy
(UPD) other than 15: phenotypes and biblio-
graphy updated. Am J Med Genet A
136:287–305
Lebre AS, Moriniere V, Dunand O et al. (2009)
Maternal uniparental heterodisomy of
chromosome 17 in a patient with nephro-
pathic cystinosis. Eur J Hum Genet 17:
1019–23
Nakamura H, Sawamura D, Goto M et al. (2005)
Epidermolysis bullosa simplex associated
with pyloric atresia is a novel clinical subtype
caused by mutations in the plectin gene
(PLEC1). J Mol Diagn 7:28–35
Pulkkinen L, Bullrich F, Czarnecki P et al. (1997)
Maternal uniparental disomy of chromosome
1 with reduction to homozygosity of the
LAMB3 locus in a patient with Herlitz
junctional epidermolysis bullosa. Am J Hum
Genet 61:611–9
Rio M, Ozilou C, Cormier-Daire V et al. (2001)
Partial maternal heterodisomy of chromo-
some 17q25 in a case of severe mental
retardation. Hum Genet 108:511–5
Takizawa Y, Pulkkinen L, Chao SC et al.
(2000) Mutation report: complete paternal
uniparental isodisomy of chromosome 1:
a novel mechanism for Herlitz junctional
epidermolysis bullosa. J Invest Dermatol 115:
307–11
Takizawa Y, Pulkkinen L, Shimizu H et al. (1998)
Maternal uniparental meroisodisomy in the
LAMB3 region of chromosome 1 results in
lethal junctional epidermolysis bullosa.
J Invest Dermatol 110:828–31
Varki R, Sadowski S, Pfendner E et al. (2006)
Epidermolysis bullosa. I. Molecular genetics
of the junctional and hemidesmosomal
variants. J Med Genet 43:641–52
CD44-Deficient Mice Do Not Exhibit Impairment of
Epidermal Langerhans Cell Migration to Lymph Nodes
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TO THE EDITOR
CD44 is a type I transmembrane protein
that binds extracellular matrix nonsul-
fated glycosaminoglycan hyaluronan
and has an important role in cell
adhesion and migration (Isacke, 2002).
Thus, CD44 is involved with leukocyte
egress, tumor invasiveness, and metas-
tasis (Isacke, 2002).
The role of CD44 in epidermal
Langerhans cell (LC) migration to drain-
ing lymph nodes (LNs) was first eval-
uated by an antibody blocking system.
Antibodies against CD44 epitopes
inhibited emigration of LCs from the
epidermis and prevented cultured LC
binding to T-cell zones in LN-frozen
sections (Weiss et al., 1997). In a
CD44-deficient mouse system, CD44
deficiency did not impair LC emigration
from the epidermis, but significantly
influenced their LN homing (Mummert
et al., 2004). In recent years, there has
been significant progress in understand-
ing the characteristics and kinetics
of LCs. It is known that there are two
kinds of Langerinþ dendritic cells
(DCs) (definition of LCs): one resides
in the epidermis and another resides
in the dermis (Bursch et al., 2007).
They show different migration patterns
to draining LNs after immunization.
Dermal Langerinþ DC migration peaks
early at 24 hours, whereas peak migra-
tion of epidermal LC is delayed untilAbbreviations: DC, dendritic cell; LC, Langerhans cell; LN, lymph node; Th, T helper
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